Fasciola hepatica: effect of 4-amino-6-trichloroethenyl-1,3-benzenedisulfonamide on glycolysis in vitro.

doi:10.1016/0014-4894(80)90117-4

Paper

Fasciola hepatica: effect of 4-amino-6-trichloroethenyl-1,3-benzenedisulfonamide on glycolysis in vitro.

Published Apr 1, 1980 · M. Schulman, D. Valentino

Experimental parasitology

Q3 SJR score

22

Citations

1

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

4-amino-6-trichloroethenyl-1,3-benzenedisulfonamide effectively inhibits glucose uptake by mature Fasciola hepatica, potentially due to inhibition of 3-phosphoglycerate kinase and phosphoglyceromutase

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Fasciola hepatica: effect of 4-amino-6-trichloroethenyl-1,3-benzenedisulfonamide on glycolysis in vitro.

References

Citations